The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio news - first Portuguese spin out

7 Aug 2018 07:00

RNS Number : 9417W
Frontier IP Group plc
07 August 2018
 

RNS REACH / RNS

AIM: FIPP

7 August 2018

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - first Portuguese spin out developing novel technologies to print electronics onto paper

 

Frontier IP, which specialises in commercialising university intellectual property, is delighted to announce its first Portuguese spin out NTPE¹ (the "Company"), in which it is taking a 31.8 per cent stake.

 

NTPE is developing novel technology called Paper-E to print electronic circuits, sensors and semiconductors onto any cellulose-based paper and is a result of the Group's formal relationship with the Universidade Nova de Lisboa Faculty of Science and Technology ("FCT NOVA").

 

The technology replaces the silicon used in electronics with eco-friendly metal oxides and cellulose, to create "inks" that can be used in specially adapted printers and printing technologies, such as ink-jet heads. It has been developed by a research team led by Professors Rodrigo Martins and Elvira Fortunato from FCT Nova. NTPE will develop and commercialise its work.

 

There is a huge range of industrial applications for the technology, including paper-based diagnostic kits, smart packaging, logistics, and many others.

 

Because it is possible to store data in the cellulose, there are potential applications in fraud prevention - for example, to replace microchips with electronic pages in passports and other identity documents which need to be tracked.

 

Non-governmental organisations in low and middle-income countries are keen to explore the technology for use in real time lab-on-paper diagnostic solutions. This is because it does not need a power source and results can be shared via mobile phones. The technology can also produce disposable smart electronic interfaces for near field and Radio-frequency identification, RFID, communications.

 

The technology has been developed within a research group from the materials department of FCT NOVA, national scientific research centre Cenimat and the Centre of Excellence in Microelectronics, Optoelectronics and Processes.

 

They bring together more than 65 researchers dedicated to new approaches in electronic materials and applying them to build novel electronic devices and systems. Cenimat collaborates with companies and research organisations such as Samsung, Merck, ETRI, Flexenable, Osram, LG, Solvay, Eurocat, the Navigator Company, Clara Saúde, INCM, and others.

 

The research team was shortlisted by the European Patent Office ("EPO") in the Research category of its Inventor of the Year Awards 2016.

 

At the time, the then EPO president Benoît Battistelli said: "The paper-based microchips developed by Elvira Fortunato and her team have the potential to bring smart computer technology to entirely new areas of daily life."

 

NTPE has been incorporated to develop and commercialise their work.

 

Frontier IP aims to be the leading commercial partner to Portuguese universities. As well as FCT NOVA, the company also has a range of formal and informal relationships with local universities and companies.

 

Frontier IP Chief Executive Officer Neil Crabb said: "We're very pleased to take a material stake in a company developing such ground-breaking technology. Paper-E has already attracted strong interest from a wide range of potential partners."

 

Professor Rodrigo Martins said: "From dreams to reality: this has been such a great journey to develop new eco-sustainable products using Paper-E capable of revolutionising the market for a broad range of existing and emerging fields. FCT NOVA and Frontier IP are on the frontline of commercialising Portuguese technology."

 

¹The Company is incorporated in Portugal under the full name of: NTPE Research, Development and Marketing of Transistors and Electronic Paper Biosensors.

 

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Cenkos Securities plc (Nominated Adviser and Joint Broker)

T: 0131 220 6939

Neil McDonald / Beth McKiernan

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

 

NOTES TO EDITORS

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAEPKESNPEFF
Date   Source Headline
30th Nov 20225:00 pmRNSTotal Voting Rights
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million
19th May 20227:00 amRNSPublication of newsletter
12th Apr 20225:18 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSUnaudited Half Year Results
14th Feb 20227:00 amRNSSale of shares in Exscientia
11th Feb 20225:04 pmRNSHolding(s) in Company
11th Feb 20222:05 pmRNSHolding(s) in Company
10th Feb 20227:00 amRNSCambridge Raman Imaging wins European Union grant
25th Jan 20227:00 amRNSSale of shares in Exscientia
17th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update
11th Jan 20227:00 amRNSCelerum launch first commercial product
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company
28th Apr 20217:01 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.